Trial Profile

A Prospective, Randomized, Open-Label, Multicenter Study Evaluating the Effects on Cognitive Functions of Adjuvant Endocrine Therapy in Postmenopausal Women With Breast Cancer.

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tamoxifen (Primary) ; Anastrozole; Exemestane; Letrozole
Indications Breast cancer
Focus Pharmacodynamics
Acronyms MNEMOSYNE

Most Recent Events

08 Dec 2012 Preliminary results presented at the 35th Annual San Antonio Breast Cancer Symposium.
08 Dec 2012 Status changed from recruiting to active, no longer recruiting based on results reported in SABCS abstract.
21 Jan 2011 Biomarkers information updated

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com